Edition:
United States

Amphastar Pharmaceuticals Inc (AMPH.OQ)

AMPH.OQ on NASDAQ Stock Exchange Global Select Market

16.12USD
2:56pm EDT
Change (% chg)

$-0.44 (-2.66%)
Prev Close
$16.56
Open
$16.34
Day's High
$16.59
Day's Low
$16.00
Volume
116,888
Avg. Vol
78,827
52-wk High
$20.44
52-wk Low
$14.40

Chart for

About

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. The Company has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products.... (more)

Overall

Beta: 1.28
Market Cap(Mil.): $771.93
Shares Outstanding(Mil.): 46.61
Dividend: --
Yield (%): --

Financials

  AMPH.OQ Industry Sector
P/E (TTM): -- 28.62 32.94
EPS (TTM): -0.21 -- --
ROI: -2.71 13.26 12.79
ROE: -3.07 14.99 14.67

BRIEF-Amphastar Pharmaceuticals Receives FDA Approval For Calcium Chloride Injection

* AMPHASTAR PHARMACEUTICALS RECEIVES FDA APPROVAL FOR CALCIUM CHLORIDE INJECTION

May 14 2018

BRIEF-Amphastar Announces Approval For Sodium Nitroprusside Injection, USP

* AMPHASTAR ANNOUNCES APPROVAL FOR SODIUM NITROPRUSSIDE INJECTION, USP

Dec 19 2017

BRIEF-Amphastar Announces Approval For Medroxyprogesterone Acetate Injectable Suspension, USP

* AMPHASTAR ANNOUNCES APPROVAL FOR MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION, USP

Nov 29 2017

Earnings vs. Estimates